Frank Dekker partner in funded Horizon Europe project
The team of Prof. Frank Dekker of the Groningen Research Institute of Pharmacy (GRIP) participates in a Horizon Europe project that was recently funded. The project is called 'In Armor' and concerns the pre-clinical development of small molecule inhibitors of histone lysine deacetylases (HDAC) for the induction of antimicrobial peptides. The project will be performed by a consortium of 16 participants from 11 different European countries with a total budget of EUR 6 million. The Dekker team is funded with EUR 390,000 to work on the synthesis and characterization of a focussed collection of HDAC inhibitors that will be taken into pre-clinical development.
| Last modified: | 15 June 2023 4.23 p.m. |
More news
-
29 April 2025
Impact | Rubber recycling
In the coming weeks the nominees for the Ben Feringa Impact Award 2025 will introduce themselves and their impactful research or project. This week: Francesco Picchioni on his innovative way to recycle rubber.
-
29 April 2025
Impact | Improving Human-AI Decision-Making in healthcare
In the coming weeks the nominees for the Ben Feringa Impact Award 2025 will introduce themselves and their impactful research or project. This week: Andra Cristiana Minculescu on her research project on Human-AI Decision-Making in healthcare.
-
28 April 2025
Engineering Smart Decisions for a Dynamic World
Dynamical systems, i.e. mathematical models that describe how things evolve over time, are at the heart of much of the modern world. The real challenge, however, lies in shaping the systems’ behaviour to achieve a specific goal.